Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma ; volume:10 ; number:1 ; day:5 ; month:1 ; year:2017 ; pages:1-11 ; date:12.2017
Journal of hematology & oncology ; 10, Heft 1 (5.1.2017), 1-11, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Feng, Kai-chao
- Contributor
-
Guo, Ye-lei
Liu, Yang
Dai, Han-ren
Wang, Yao
Lv, Hai-yan
Huang, Jian-hua
Yang, Qing-ming
Han, Wei-dong
SpringerLink (Online service)
- DOI
-
10.1186/s13045-016-0378-7
- URN
-
urn:nbn:de:1111-201702216353
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Feng, Kai-chao
- Guo, Ye-lei
- Liu, Yang
- Dai, Han-ren
- Wang, Yao
- Lv, Hai-yan
- Huang, Jian-hua
- Yang, Qing-ming
- Han, Wei-dong
- SpringerLink (Online service)
Other Objects (12)
Chimeric toxins for specific targeting of cancer cells
Imaging and selective elimination of glioblastoma stem cells with theranostic near-infrared-labeled CD133-specific antibodies
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
Construction and evaluation of a novel humanized HER2-specific chimeric receptor
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery
Chimeric toxins for specific targeting of cancer cells
Imaging and selective elimination of glioblastoma stem cells with theranostic near-infrared-labeled CD133-specific antibodies
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
Construction and evaluation of a novel humanized HER2-specific chimeric receptor
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery
Chimeric toxins for specific targeting of cancer cells
Imaging and selective elimination of glioblastoma stem cells with theranostic near-infrared-labeled CD133-specific antibodies
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Cytomegalovirus specific activation of cytotoxic T-lymphocytes by chimeric immunoreceptors
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
Construction and evaluation of a novel humanized HER2-specific chimeric receptor
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma